KA: Kineta, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 6.37
Enterprise Value ($M) 1.52
Book Value ($M) 3.06
Book Value / Share 0.27
Price / Book 2.08
NCAV ($M) -1.25
NCAV / Share -0.11
Price / NCAV -5.11

Profitability (mra)
Return on Invested Capital (ROIC) -3.22
Return on Assets (ROA) -1.08
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.85
Current Ratio 0.85

Balance Sheet (mrq) ($M)
Current Assets 5.98
Assets 10.28
Liabilities 7.22
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 5.44
Operating Income -15.72
Net Income -14.10
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -16.21
Cash from Investing 0.33
Cash from Financing 8.47

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
4 days ago 13D/A Bartoszek Raymond J. 16.20 103.25
02-14 13G Armistice Capital, Llc 9.99
02-12 13D/A Iadonato Shawn 9.70 15.99
02-12 13G/A Magness Charles 6.10 -1.12

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-11 10-Q Form 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 24,007 67,152 35.75
2024-05-02 7,389 8,849 83.50
2024-05-01 21,062 12,440 169.31
2024-04-30 19,356 9,266 208.89

(click for more detail)

Similar Companies
JAGX – Jaguar Health, Inc. JAN – JanOne Inc.
JSPR – Jasper Therapeutics, Inc. KALA – KALA BIO, Inc.
KPRX – Kiora Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io